IL7 and neoplasm: Our data demonstrate that following adoptive transfer, TCR-engineered TSCM-like cells generated in culture with IL-7/IL-15 maintain a reservoir in the tdLNs accounting for nearly a quarter of all CD90.1+ cells, whereas tumor-infiltrating cells express a differentiated effector memory phenotype.